Mawer Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.5M | Sell |
267,108
-27,771
| -9% | -$6.7M | 0.33% | 61 |
|
|
2025
Q1 | $71.8M | Buy |
294,879
+37,952
| +15% | +$9.24M | 0.35% | 60 |
|
|
2024
Q4 | $84.4M | Buy |
256,927
+39,042
| +18% | +$12.8M | 0.38% | 55 |
|
|
2024
Q3 | $72.9M | Buy |
217,885
+84,237
| +63% | +$28.2M | 0.33% | 54 |
|
|
2024
Q2 | $36.5M | Buy |
133,648
+295
| +0.2% | +$80.6K | 0.17% | 70 |
|
|
2024
Q1 | $46.1M | Buy |
133,353
+9,475
| +8% | +$3.28M | 0.21% | 67 |
|
|
2023
Q4 | $40M | Sell |
123,878
-38,954
| -24% | -$12.6M | 0.2% | 69 |
|
|
2023
Q3 | $58.4M | Buy |
162,832
+21,808
| +15% | +$7.82M | 0.31% | 59 |
|
|
2023
Q2 | $53.5M | Buy |
141,024
+43,880
| +45% | +$16.6M | 0.28% | 66 |
|
|
2023
Q1 | $46.5M | Buy |
97,144
+8,574
| +10% | +$4.11M | 0.25% | 69 |
|
|
2022
Q4 | $37.2M | Buy |
88,570
+18,710
| +27% | +$7.87M | 0.21% | 71 |
|
|
2022
Q3 | $29.1M | Buy |
69,860
+2,150
| +3% | +$897K | 0.18% | 73 |
|
|
2022
Q2 | $33.5M | Buy |
67,710
+27,010
| +66% | +$13.4M | 0.19% | 72 |
|
|
2022
Q1 | $22.9M | Buy |
40,700
+110
| +0.3% | +$62K | 0.11% | 79 |
|
|
2021
Q4 | $30.7M | Buy |
40,590
+218
| +0.5% | +$165K | 0.14% | 85 |
|
|
2021
Q3 | $30.1M | Sell |
40,372
-14
| -0% | -$10.4K | 0.14% | 85 |
|
|
2021
Q2 | $26M | Buy |
40,386
+52
| +0.1% | +$33.5K | 0.13% | 84 |
|
|
2021
Q1 | $23M | Buy |
40,334
+8,213
| +26% | +$4.69M | 0.13% | 83 |
|
|
2020
Q4 | $18.7M | Buy |
+32,121
| New | +$18.7M | 0.11% | 80 |
|